Tesamorelin: Best Telehealth Providers for Muscle Growth & Athletic Performance (2026)
An FDA-approved growth hormone-releasing factor analog originally indicated for HIV-associated lipodystrophy. Increasingly used off-label for body composition optimization and visceral fat reduction.
Reviewed by Dr. James Okafor, PharmDPharmDTesamorelin at a Glance
Category
Muscle Growth & Athletic Performance
Administration
Subcutaneous injection
Telehealth Providers
4 compared
Price Range
$349 – $420/mo
Typical Dose
2mg
Frequency
Once daily
Protocol Duration
26-52 weeks
Prescription
Required
Research highlight: Tesamorelin is FDA-approved (Egrifta) for HIV-associated lipodystrophy based on studies showing 15-20% reduction in visceral adipose tissue over 26 weeks — the strongest visceral fat reduction data of any GHRH analog.
What is Tesamorelin Used For?
Also known as: Egrifta
- Visceral fat reduction
- Growth hormone stimulation
- Body composition
- Metabolic health
How Tesamorelin Works
Tesamorelin is a GHRH analog — a synthetic version of growth hormone-releasing hormone — that stimulates pituitary GH secretion. Unlike sermorelin (which covers the first 29 amino acids of GHRH), tesamorelin covers the full 44-amino-acid sequence conjugated to a trans-2-hexenoic acid moiety for stability. It is FDA-approved (Egrifta) for HIV-associated lipodystrophy and demonstrates particularly potent visceral fat reduction through GH-mediated lipolysis in abdominal adipose tissue.
TesamorelinDosing & Administration
| Typical Dose | 2mg |
| Frequency | Once daily |
| Protocol Duration | 26-52 weeks |
| Route | Subcutaneous injection |
Dosing information is for educational purposes only. Your prescribing physician will determine the appropriate dose based on your medical history and treatment goals.
What to Expect from Tesamorelin
The FDA approval for HIV lipodystrophy is based on studies showing 15–20% reduction in visceral adipose tissue (VAT) over 26 weeks. Off-label use for body recomposition shows meaningful visceral fat reduction at 3–6 months. GH and IGF-1 levels typically rise 30–50% within the first 4 weeks. Many users also report improvements in energy, sleep, and muscle tone.
Who Should Consider Tesamorelin?
- Adults with excess visceral fat (abdominal adiposity)
- Patients with metabolic syndrome features
- Those with suboptimal GH/IGF-1 levels from aging
- Patients whose primary goal is visceral fat reduction over muscle growth
Tesamorelin Side Effects
- Injection site reactions (common — redness, bruising, pain)
- Peripheral edema (water retention)
- Arthralgia (joint pain)
- Carpal tunnel syndrome symptoms
- Flushing
- Blood glucose elevation (monitor in pre-diabetic patients)
This is not a complete list of side effects. Always consult your prescribing physician before starting Tesamorelin.
4 Telehealth Providers Offering Tesamorelin
Sorted by lowest price. All providers require a prescription from a licensed physician.
| Provider | Price | Dose | Rating | Consultation | Lab Testing |
|---|---|---|---|---|---|
| Hone Health Pittsburgh, PA | $349/monthly | 2mg/day | 4.0/5 | Async Telehealth | Included |
| Defy Medical Tampa, FL | $350/monthly | 2mg/day | 4.1/5 | Video Telehealth | Included |
| Evolve Telemed San Diego, CA | $380/monthly | 2mg/day | 4.0/5 | Video Telehealth | Included |
| TruLife Health Scottsdale, AZ | $420/monthly | 2mg/day | 4.1/5 | Video Telehealth | Included |
How to Choose the Best Telehealth Provider for Growth Hormone Peptides
Growth hormone optimization requires accurate diagnosis, careful dosing, and lab monitoring. These are the criteria that matter most.
Baseline Lab Requirements
IGF-1, fasting glucose, HbA1c, and a metabolic panel should be checked before starting any GH peptide protocol. Providers who skip labs cannot properly assess response or monitor safety.
Protocol Customization
GH peptides vary widely in mechanism (GHRH analogs, GH secretagogues, direct GH stimulators). The best providers select based on your specific goals — body recomposition, sleep, anti-aging, or performance.
Stacking Knowledge
GHRH analogs (CJC-1295, sermorelin) and GH secretagogues (ipamorelin, GHRP-2) work synergistically. Providers experienced with peptide stacking can design protocols that amplify results through complementary mechanisms.
Blood Sugar Monitoring
GH elevation can reduce insulin sensitivity over time. Responsible providers monitor fasting glucose and HbA1c at baseline and periodically, especially in pre-diabetic patients or those on MK-677.
Dosing Titration
Growth hormone peptides should start low and titrate based on lab response (IGF-1 levels) and side effects. Providers who prescribe a fixed dose without follow-up labs are not optimizing your protocol.
Clear Cycle Planning
Most GH peptide protocols run 3–6 months before reassessment. Look for providers with structured cycle plans, including when to re-test labs, when to adjust, and when to cycle off.
Frequently Asked Questions About Tesamorelin
Is tesamorelin FDA-approved for weight loss?
Tesamorelin (Egrifta) is FDA-approved specifically for visceral adiposity in HIV-infected adults with lipodystrophy — not for general obesity. Off-label use for body recomposition and visceral fat reduction in non-HIV patients is common in anti-aging and hormone optimization medicine.
How does tesamorelin compare to sermorelin?
Both are GHRH analogs, but tesamorelin covers the full 44-amino-acid sequence and has a longer half-life (thanks to its trans-2-hexenoic acid modification). Clinical evidence shows tesamorelin produces stronger GH stimulation and more pronounced visceral fat reduction than sermorelin. It is typically the preferred choice when visceral fat is the primary treatment target.
Can tesamorelin be used long-term?
The FDA approval is based on 26-week and 52-week trials. Long-term use (beyond 52 weeks) requires ongoing monitoring of blood glucose and IGF-1 levels. When tesamorelin is discontinued, visceral fat typically returns over time — suggesting it may need to be a long-term intervention for sustained results.
Who is the ideal candidate for tesamorelin?
Ideal candidates are adults with excess visceral fat, suboptimal GH/IGF-1 levels (common in aging), and metabolic syndrome features. It is particularly suited to patients whose primary goal is visceral fat reduction rather than muscle growth — for whom it outperforms most other GHRH analogs.
Tesamorelin Alternatives for Muscle Growth & Athletic Performance
Compare other muscle growth & athletic performance peptides available through telehealth.
CJC-1295 / Ipamorelin
A combination of a growth hormone-releasing hormone analog (CJC-1295) and a growth hormone secretagogue (Ipamorelin). Together they stimulate natural growth hormone production without significantly raising cortisol or prolactin.
GHRP-2
A synthetic hexapeptide that stimulates pituitary growth hormone secretion by binding ghrelin receptors. Produces strong, pulsatile GH release without significantly raising cortisol. Often stacked with GHRH analogs like CJC-1295 for synergistic effect.
GHRP-6
One of the original synthetic growth hormone secretagogues. Similar to GHRP-2 but with a pronounced ghrelin-mimicking appetite-stimulating effect. Favored by those looking to increase caloric intake alongside growth hormone optimization.
IGF-1 LR3
A long-acting analog of insulin-like growth factor-1 (IGF-1) with an arginine substitution that reduces binding to IGF-binding proteins, extending its half-life. IGF-1 is the primary downstream mediator of growth hormone's anabolic effects.
MK-677
An oral growth hormone secretagogue that mimics the action of ghrelin, stimulating growth hormone release from the pituitary gland. Unlike injectable peptides, MK-677 is taken orally and has a long half-life.
Sermorelin
A growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to produce and secrete growth hormone naturally. Often used as a gentler alternative to direct HGH therapy.